AstraZeneca Pharma India Limited has announced the appointment of Ms. Tanya Sanish as the new Company Secretary and Compliance Officer. This appointment is effective from February 23, 2026, following the recommendation of the Nomination and Remuneration Committee and approval by the Board of Directors. Ms. Sanish brings over 15 years of corporate governance experience, most recently serving in a similar capacity at Piramal Pharma Limited.
Key Management Change Announced
AstraZeneca Pharma India Limited has formally communicated a significant change in its key managerial personnel. The Board of Directors has approved the appointment of Ms. Tanya Sanish to serve as the Company Secretary and Compliance Officer for the organization.
Effective Date and Tenure
This official appointment is set to take effect on February 23, 2026. The term of appointment for Ms. Sanish has been designated as Full – time employment, ensuring continuous leadership in regulatory compliance functions.
Profile of Ms. Tanya Sanish
Ms. Sanish is an accomplished Corporate Governance professional, possessing over 15 years of dedicated experience in strengthening governance structures and driving compliance initiatives. Her expertise covers a wide spectrum, including Board governance, advisory roles, compliance with corporate and Indian securities laws, capital markets transactions, Mergers & Acquisitions (M&A), and cross-border structuring.
Previously, she played a crucial role in compliance for major fundraising activities such as rights issues and Qualified Institutional Placements (QIPs). She currently holds the position of Company Secretary and Compliance Officer at Piramal Pharma Limited, overseeing compliance for its listed entity and subsidiaries across multiple jurisdictions. Ms. Sanish is an Associate Member of the Institute of Company Secretaries of India (ICSI) and holds a Bachelor of Law degree from Mumbai University.
Director Relationships
The company confirmed that there are Not Applicable disclosures regarding relationships between Ms. Sanish and the existing directors of AstraZeneca Pharma India Limited.
Source: BSE
